share_log

4: Statement of changes in beneficial ownership of securities-Officer Sragovicz Adam

SEC ·  May 16 10:26
Summary by Futu AI
Adam Sragovicz, the Chief Financial Officer of Conduit Pharmaceuticals, has initiated the disposal of 74,545 Restricted Stock Units (RSUs) on May 15, 2024. The transaction is currently in progress and involves the company's common stock. The RSUs were disposed of at no cost, and following the transaction, Sragovicz will hold zero shares in the company. This move could potentially signal changes within the company's financial leadership or strategy.
Adam Sragovicz, the Chief Financial Officer of Conduit Pharmaceuticals, has initiated the disposal of 74,545 Restricted Stock Units (RSUs) on May 15, 2024. The transaction is currently in progress and involves the company's common stock. The RSUs were disposed of at no cost, and following the transaction, Sragovicz will hold zero shares in the company. This move could potentially signal changes within the company's financial leadership or strategy.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.